Research Progress on NK Cell Receptors and Their Signaling Pathways

被引:81
作者
Chen, Yingying [1 ]
Lu, Dan [1 ]
Churov, Alexey [2 ]
Fu, Rong [1 ]
机构
[1] Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China
[2] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia
基金
中国国家自然科学基金;
关键词
NATURAL-KILLER-CELLS; PHOSPHOLIPASE C-GAMMA; NTB-A RECEPTORS; INHIBITORY RECEPTOR; HLA-E; DIFFERENTIAL REQUIREMENTS; TYROSINE KINASE; MOLECULAR-BASIS; CUTTING EDGE; MEDIATED NK;
D O I
10.1155/2020/6437057
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Natural killer cells (NK cells) play an important role in innate immunity. NK cells recognize self and nonself depending on the balance of activating receptors and inhibitory receptors. After binding to their ligands, NK cell receptors trigger subsequent signaling conduction and then determine whether NK is activated or inhibited. Furthermore, NK cell response includes cytotoxicity and cytokine release, which is tightly related to the activation of NK cell-activating receptors and the inhibition of inhibitory receptors on the surfaces of NK cells. The expression and function of NK cell surface receptors also alter in virus infection, tumor, and autoimmune diseases and influence the occurrence and development of diseases. So, it is important to understand the mechanism of recognition between NK receptors and their ligands in pathological conditions and the signaling pathways of NK cell receptors. This review mainly summarizes the research progress on NK cell surface receptors and their signal pathways.
引用
收藏
页数:14
相关论文
共 121 条
[1]
The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment [J].
Agresta, Laura ;
Hoebe, Kasper H. N. ;
Janssen, Edith M. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[2]
Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy [J].
Aldhamen, Yasser A. ;
Seregin, Sergey S. ;
Aylsworth, Charles F. ;
Godbehere, Sarah ;
Amalfitano, Andrea .
INTERNATIONAL IMMUNOLOGY, 2014, 26 (05) :291-+
[3]
The Natural Cytotoxicity Receptors in Health and Disease [J].
Barrow, Alexander David ;
Martin, Claudia Jane ;
Colonna, Marco .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[4]
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44 [J].
Baychelier, Florence ;
Sennepin, Alexis ;
Ermonval, Myriam ;
Dorgham, Karim ;
Debre, Patrice ;
Vieillard, Vincent .
BLOOD, 2013, 122 (17) :2935-2942
[5]
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway [J].
Billadeau, DD ;
Upshaw, JL ;
Schoon, RA ;
Dick, CJ ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :557-564
[6]
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation [J].
Binstadt, BA ;
Brumbaugh, KM ;
Dick, CJ ;
Scharenberg, AM ;
Williams, BL ;
Colonna, M ;
Lanier, LL ;
Kinet, JP ;
Abraham, RT ;
Leibson, PJ .
IMMUNITY, 1996, 5 (06) :629-638
[7]
The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering [J].
Bottino, C ;
Biassoni, R ;
Millo, R ;
Moretta, L ;
Moretta, A .
HUMAN IMMUNOLOGY, 2000, 61 (01) :1-6
[8]
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567
[9]
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[10]
2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090